Seeking Alpha
 

AxoGen, Inc. (AXGN)

- NASDAQ
  • Cockrell Group | Send Message 4 May

    AxoGen, Inc. $AXGN CEO Karen Zaderej, expected to appear on FOX Business' "After the Bell" with Liz Claman today at 4PM ET
    Reply
      • Tedra DeSue | Send Message 17 Nov 2014

        This Biotech Micro Cap Is Undervalued; Primed To Buy $PDLI, $AXGN http://seekingalpha.com/p/22b5z
        Reply
          • snakepitt1 | Send Message 31 Dec 2013

            $AXGN Nerve regeneration process that is proven to work. Stock will skyrocket once company receives more press. Helping veterans right now
            Reply
              • Cockrell Group | Send Message 3 Dec 2013

                $AXGN CEO, Karen Zaderej to appear on Bloomberg TV tonight @ 5:10 PM
                Reply
                  • Cockrell Group | Send Message 30 Oct 2013

                    $AXGN (Px tgt: $5.75) to release results today after close. Analysts expect 3Q13 Revs of $3 million vs. $2 million in 3Q12.
                    Reply
                      • Cockrell Group | Send Message 9 Aug 2013

                        $AXGN completed $18 Million underwritten offering at a price of $3.00 per share.
                        Reply
                          • Cockrell Group | Send Message 9 Aug 2013

                            $AXGN shares UPLISTED to NASDAQ under symbol AXGN
                            Reply
                              • Cockrell Group | Send Message 18 Apr 2013

                                JMP Securities initiates coverage on $AXGN shares with an OUTPERFORM rating and an $8.00 share price.
                                Reply
                                  • Cockrell Group | Send Message 12 Apr 2013

                                    $AXGN CEO Karen Zaderej to appear on FOX Business at 10:25AM ET to discuss Axogen's nerve repair solutions in regenerative medicine.
                                    Reply
                                      • Cockrell Group | Send Message 28 Dec 2012

                                        $AXGN Featured in WSJ: Graft Helps Nerves Regrow December 27, 2012 http://on.wsj.com/VbqhXX
                                        Reply
                                          Visit Seeking Alpha's
                                          AXGN vs. ETF Alternatives
                                          Company Description
                                          AxoGen Inc is a regenerative medicine company. The Company has a portfolio of proprietary products and technologies for peripheral nerve reconstruction and regeneration.